Unknown

Dataset Information

0

Binding to the open conformation of HIV-1 protease.


ABSTRACT: A recent crystal structure of HIV-1 protease (HIVp) was the first to experimentally observe a ligand targeting an open-flap conformation. Researchers studying a symmetric pyrrolidine inhibitor found that two ligands cocrystallized with the protease, forcing an unusual configuration and unique crystallographic contacts. One molecule is centered in the traditional binding site (? pose) and the other binds between the flaps (? pose). The ligands stack against each other in a region termed the "eye" site. Ligands bound to the eye site should prevent flap closure, but it is unclear if the pyrrolidine inhibitors or the crystal packing are causing the open state. Molecular dynamics simulations were used to examine the solution-state behavior of three possible binding modes: the ternary complex of HIVp+?? and the binary complexes, HIVp+? and HIVp+?. We show that HIVp+? is the most stable of the three states. During conformational sampling, ? takes an asymmetric binding pose, with one naphthyl ring occupying the eye site and the other reoriented down to occupy positions seen with traditional inhibitors. This finding supports previous studies that reveal a requirement for asymmetric binding at the eye site. In fact, if the ? pose is modified to splay both naphthyl rings across the binding site like traditional inhibitors, one ring consistently flips to occupy the eye site. Our simulations reveal that interactions to the eye site encourage a conformationally restrained state, and understanding those contacts may aid the design of ligands to specifically target alternate conformations of the protease.

SUBMITTER: Lexa KW 

PROVIDER: S-EPMC3124008 | biostudies-literature | 2011 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Binding to the open conformation of HIV-1 protease.

Lexa Katrina W KW   Carlson Heather A HA  

Proteins 20110520 7


A recent crystal structure of HIV-1 protease (HIVp) was the first to experimentally observe a ligand targeting an open-flap conformation. Researchers studying a symmetric pyrrolidine inhibitor found that two ligands cocrystallized with the protease, forcing an unusual configuration and unique crystallographic contacts. One molecule is centered in the traditional binding site (α pose) and the other binds between the flaps (β pose). The ligands stack against each other in a region termed the "eye"  ...[more]

Similar Datasets

| S-EPMC1892946 | biostudies-literature
| S-EPMC3769432 | biostudies-literature
| S-EPMC10224173 | biostudies-literature
| S-EPMC3056339 | biostudies-literature
| S-EPMC4076034 | biostudies-literature
| S-EPMC4737996 | biostudies-literature
| S-EPMC1462710 | biostudies-other
| S-EPMC5889391 | biostudies-literature
| S-EPMC4767006 | biostudies-literature
| S-EPMC2981608 | biostudies-literature